Insulin and bone: A clinical and scientific review

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 1, 1997, Pages 5-17

  Thomas, David M ^a   Ng, Kong Wah ^a   Best, James D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; BONE METABOLISM; CELL DIFFERENTIATION; DIABETES MELLITUS; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; HYPEROSTOSIS; HYPOINSULINEMIA; MITOGENICITY; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030727590     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Review

References (141)

1. Canalis E. Systemic and local factors and the maintenance of bone quality. Calcif. Tissue Int. 1993; 53 (Suppl. 1): S90-2.
2. Luben RA, Wong GL, Cohn DV. Biochemical characterisation with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology 1976; 99: 526-534.
3. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ. Functional properties of hormonally responsive cultured and malignant rat osteoblastic cells. Endocrinology 1981; 108: 213-219.
4. Majeska RJ, Rodan SB, Rodan GA. Parathyroid hormoneresponsive clonal cell lines from rat osteosarcoma. Endocrinology 1980; 107: 1494-1502.
5. Nijweide PJ, Bruger EH, Feyen JHM. Cells of bone: proliferation and hormonal regulation. Physiol. Rev. 1986; 66: 855-886.
6. Ng KW, Gummer PR, Michelangeli VP, Bateman JF, Mascara T, Cole WG, Martin TJ. Regulation of alkaline phosphatase expression in a neonatal rat clonal calvarial cell strain by retinoic acid. J. Bone Min. Res. 1988; 3: 53-61.
7. Zhou H, Hammonds RG Jr, Findlay DM, Fuller PJ, Martin TJ, Ng KW. Retinoic acid modulation of mRNA levels in malignant, nontransformed, and immortalized osteoblasts. J. Bone Min. Res. 1991; 6: 767-777.
8. Heath JK, Rodan SB, Yoon K, Rodan GA. Rat calvarial cell lines immortalized with SV-40 Large T antigen: constitutive and retinoic acid-inducible expression of osteoblastic features. Endocrinology 1989; 124: 3060-3068.
9. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr. Rev. 1995; 16: 117-142.
10. Flier JS. Lilly lecture: syndromes of insulin resistance. Diabetes 1992; 41: 1207-1219.
11. Taylor SI. Lilly lecture: molecular mechanisms of insulin resistance. Diabetes 1992; 41: 1473-1490.
12. De Luise MA, Harker M. Insulin Stimulation of Na+/K+ pump in clonal rat osteosarcoma cells. Diabetes 1988; 37: 33-37.
13. Ituarte EA, Ituarte HG, lida-Klein A, Hahn TJ. Characterisation of insulin binding in the UNR 106-01 rat osteosarcoma cell. J. Bone Min. Res. 1989; 4: 69-73.
14. Pun KK, Lau P, Ho PW. The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J. Bone Min. Res. 1989; 4:853-862.
15. Levy JR, Murray E, Manolagas S, Olefsky JM. Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells. Endocrinology 1986; 119: 1786-1792.
16. Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD. Insulin receptor expression in bone. J. Bone Min. Res. 1996, 11: 1312-1320.
17. Thomas DM, Rogers SD, Ng KW, Best JD. Regulation of glucose transport and insulin receptor by dexamethasone in UMR 106-01, a clonal osteosarcoma cell line. J. Mol. Endocrinol. 1996, 17: 7-17.
18. Mamula PW, McDonald AR, Brunetti A, Okayabashi Y, Wong KY, Maddux BA, Logsdon C, Goldfine ID. Regulating insulin-receptor-gene expression by differentiation and hormones. Diabetes Care 1990; 13: 288-301.
19. Hahn TJ, Westbrook SL, Sullivan TL, Goodman WG, Halstead LR. Glucose transport in osteoblast-enriched bone explants: characterization and insulin regulation. J. Bone Min. Res. 1988; 3: 359-365.
20. Ituarte EA, Ituarte HG, Hahn TJ. Insulin and glucose regulation of glycogen synthase in rat calvarial osteoblastlike cells. Calcif. Tissue Int. 1988; 42: 351-357.
21. Ituarte EA, Halstead LR, lida-Klein A, Ituarte HG, Hahn TJ. Glucose transport system in UMR 106-01 osteoblastic osteosarcoma cells: regulation by insulin. Calcif. Tissue Int. 1989; 45: 27-33.
22. Thomas DM, Rogers SD, Sleeman MW, Pasquini GM, Bringhurst FR, Ng KW, Zajac JD, Best JD. Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal osteogenic sarcoma cell line. J. Mol. Endocrinol. 1995; 14: 263-275.
23. Hahn TJ, Downing SJ, Phang JM. Insulin effect on amino acid transport in bone: dependence on protein synthesis and Na+. Am. J. Physiol. 1971; 220: 1717-1723.
24. Hickman J, McElduff A. Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106-01: an osteoblast-like cell. Endocrinology 1989; 124: 701-706.
25. lida-Klein A, Varlotta V, Hahn TJ. Protein kinase C activity in UMR-106-01 cells: effects of parathyroid hormone and insulin. J. Bone Min. Res. 1989; 4: 767-774.
26. lida-Klein A, Hahn TJ. Insulin acutely suppresses parathyroid hormone second messenger generation in UMR106-01 osteoblast-like cells: differential effects on phospholipase C and adenylate cyclase activation. Endocrinology 1991; 129: 1016-1024.
27. Felsenfeld AJ, lida-Klein A, Hahn TJ. Interrelationship between parathyroid hormone and insulin: effects on DMA synthesis in UMR-106-01 cells. J. Bone Min. Res. 1992; 7: 1319-1325.
28. Armbrecht HJ, Hodam TL, Boltz MA, Wongsurawat N. Insulin markedly potentiates the capacity of parathyroid hormone to increase expression of 25 (OH)D-24-hydroxylase in rat osteoblastic cells. ( S510) 1995. American Society for Bone and Mineral Research Conference.
29. Canalis E. Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 1983; 32: 14-20.
30. Kunkler KJ, Everett LM, Breedlove DK, Kempson SA. Insulin stimulates sodium-dependent phosphate transport by osteoblast-like cells. Am. J. Physiol. 1991; 260: E751-E755.
31. Canalis E. Effect of insulin-like growth factor I on DNA and protein synthesis in cultured rat calvariae. J. Clin. Invest. 1980; 66: 709-719.
32. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988; 122: 254-260.
33. Craig RG, Rowe DW, Petersen DN, Kream BE. Insulin increases the steady state level of a -1(1) procollagen mRNA in the osteoblast-rich segment of fetal rat calvaria. Endocrinology 1989; 125: 1430-1437.
34. Yano H, Ohya K, Amagasa T. Effect of insulin on in vitro bone formation in fetal rat parietal bone. Endocr. J. 1994; 41: 293-300.
35. Kream BE, Smith MD, Canalis E, Raisz LG. Characterization of the effect of insulin on collagen synthesis in fetal rat bone. Endocrinology 1985; 116: 296-302.
36. Ernst M, Froesch ER. Osteoblastlike cells in a serum-free methylcellulose medium form colonies: effects of insulin and insulinlike growth factor I. Calcif. Tissue Int. 1987; 40: 27-34.
37. Thiebaud D, Ng KW, Findlay DM, Harker M, Martin TJ. Insulinlike growth factor 1 regulates mRNA levels of osteonectin and pro-alpha 1 (l)-collagen in clonal preosteoblastic calvarial cells. J. Bone Min. Res. 1990; 5: 761-767.
38. Soskolne WA, Schwartz, Ornoy A. The development of fetal mice long bones in vitro: an assay of bone modeling. Bone 1986; 7: 41-48.
39. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr. Rev. 1992; 13: 66-80.
40. Karasik A, Hattori M. Use of animal models in the study of diabetes. In: Kahn, C. R., Weir, G. C., editors, Joslin's Diabetes Mellitus, 13th edition 1994; 317-320.
41. Weiss RE, Reddi AH. Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation. Am. J. Physiol. 1980; 238: E200-E207.
42. Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV. Effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in rats. J. Lab. Clin. Med. 1981; 97: 231-235.
43. Goodman WG, Hori MT. Diminished bone formation in experimental diabetes. Diabetes 1984; 33: 825-831.
44. Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, Froesch ER. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 1986; 323: 169-171.
45. Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling. Endocrinology 1988; 123: 290-295.
46. Heinze E, Vetter U, Voigt KH. Insulin stimulates skeletal growth in vivo and in vitro-comparison with growth hormone in rats. Diabetologia 1989; 32: 198-202.
47. Verhaeghe J, Suiker AM, Nyomba BL, Visser WJ, Einhorn TA, Dequeker J. Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 1989; 124: 573-582.
48. Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Thornasset M, Einhorn TA, Faierman E, Bouillon R. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 1990; 39: 477-482.
49. Sasaki T, Kaneko H, Ramamurthy NS, Golub LM. Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat. Rec. 1991; 231: 25-34.
50. Locatto ME, Abranzon H, Caferra D, Fernandez MC, Alloatti R, Puche RC. Growth and development of bone mass in untreated alloxan diabetic rats. Effects of collagen glycosylation and parathyroid activity on bone turnover. Bone Mineral 1993; 23: 129-144.
51. Waud CE, Marks SC Jr, Lew R, Baran DT. Bone mineral density in the femur and lumbar vertebrae decreases after twelve weeks of diabetes in spontaneously diabetesprone BB/Worcester rats. Calcif. Tissue Int. 1994; 54: 237240.
52. Verhaeghe J, Suiker AM, Einhorn TA, Geusens P, Visser WJ, Van Herck E, Van Bree R, Magitsky S, Bouillon R. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomised rats. J. Bone Min. Res. 1994; 9: 1657-1667.
53. Hou JC-H, Zernicke RF, Barnard RJ. Experimental diabetes, insulin treatment, and femoral neck morphology and biomechanics in rats. Clin. Orthopaed. Rel. Res. 1991; 264: 278-285.
54. Cooke PS, Nicoll CS. Role of insulin in the growth of fetal rat tissues. Endocrinology 1984; 114: 638-643.
55. Ishida H, Seino Y, Taminato T, Usami M, Takeshita N, Moriuchi S, Akiyama Y, Hara K, et al. Circulating levels and bone contents of bone gamma-carboxyglutamic acidcontaining protein are decreased in streptozocin-induced diabetes. Possible marker for diabetic osteopenia. Diabetes 1988; 37: 702-706.
56. Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL. Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology 1981; 108: 2228-2233.
57. Verhaeghe J, Suiker AM, Visser WJ, Van Herck E, Van Bree R, Bouillon R. The effects of systemic insulin, insulinlike growth factor-l and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. Endocrinology 1992; 134: 485-492.
58. Takeshita N, Ishida H, Yamamoto T, Koh G, Kurose T, Tsuji K, Okamoto Y, Ikeda H, Seino Y. Circulating levels and bone contents of bone g-carboxyglutamic acid-containing protein in rat models of non-insulin-dependent diabetes mellitus. Acta Endocrinol. 1993; 128: 69-73.
59. Levy J, Teitelbaum SL, Gavin JR, Fausto A, Kurose H, Avioli LV. Bone calcification and calcium homeostasis in rats with non-insulin-dependent diabetes induced by streptozocin. Diabetes 1985; 34: 365-372.
60. Amir G, Adler JH, Menczel J. Histomorphometric analysis of weight bearing bones of diabetic and non-diabetic sand rats (Psammomys obesus). Diabetes Res. 1991; 17: 135-137.
61. Silberberg R. Morphometric analysis of cancellous bone of young diabetic and non-diabetic sand rats (Psammomys obesus). Diabetes Res. 1987; 5: 149-151.
62. Matsumoto T, Kawanobe Y, Ezawa I, Shibuya N, Hâta K, Ogata E. Role of insulin in the increase in serum 1,25dihydroxyvitamin D concentrations in response to phosphorous deprivation in streptozotocin-induced diabetic rats. Endocrinology 1986; 118: 1440-1444.
63. Foldes J, Shin MS, Levy J. Bone structure and calcium metabolism in obese Zucker rats. Int. J. Obes. Rel. Metab. Disorders 1992; 16: 95-102.
64. Yamaguchi M, Ozaki K, Hoshi T. Simulated weightlessness and bone metabolism: impairment of glucose consumption in bone tissue. Res. Exp. Med. 1991; 191: 105111.
65. Yamaguchi M, Hoshi T. Simulated weightlessness and bone metabolism: gravitational stimulation enhances insulin sensitivity. Res. Exp. Med. 1992; 192: 345-353.
66. Yamaguchi M, Kishi S, Hoshi T. Effect of insulin administration on bone formation is impaired in rats with skeletal unloading. Biol. Pharm. Bull. 1993; 16:1179-1181.
67. Machwate M, Zerath E, Holy X, Hott M, Modrowski D, Malouvier A, Marie PJ. Skeletal unloading in rats decreases proliferation of rat bone and marrow-derived osteoblastic cells. Am. J. Physiol. 1993; 264: E790-E799.
68. Cornish J, Gallon KE, Edgar S, Reid SR. Anabolic effects of insulin on bone in vivo. ( M384) 1995. American Society for Bone and Mineral Research Conference.
69. Martineau-Doize H, McKee MD, Warshawsky H, Bergeron JJM. In vivo demonstration by radioautography of binding sites for insulin in liver, kidney, and calcified tissues of the rat. Anat. Rec. 1986; 214: 130-140.
70. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. Diabetes Care 1992; 15: 318-368.
71. Bouillon R. Diabetic bone disease. Calcif. Tissue Int. 1991; 49: 155-160.
72. Seino Y, Ishida H. Diabetic osteopenia: pathophysiology and clinical aspects. Diabetes/Metabolism Reviews 1995; 11: 21-35.
73. Levin ME, Boisseau VC, Avioli LV. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. New Engl. J. Med. 1976; 294: 241-245.
74. Rosenbloom AL, Lezotte DC, Weber FT, Gudat J, Heller DR, Weber ML, Klein S, Kennedy BB. Diminution of bone mass in childhood diabetes. Diabetes 1977; 26: 10521055.
75. McNair P, Madsbad S, Christensen MS, Christiansen C, Faber OK, Binder C, Transbol I. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh.) 1979; 90: 463-472.
76. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Osteopenia in juvenile diabetes. Calcif. Tissue Int. 1981; 33: 455-457.
77. Wiske PS, Wentworth SM, Norton JA Jr, Epstein S, Johnston CC Jr. Evaluation of bone mass and growth in young diabetics. Metabolism 1982; 31: 848-854.
78. Hui SL, Epstein S, Johnston CC. A prospective study of bone mass in patients with type I diabetes. J. Clin. Endocrinol. Metab. 1985; 60: 74-80.
79. Auwerx J, Dequeker J, Bouillon R, Guesens P, Nijs J. Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 1988; 37: 8-12.
80. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes 1995; 44: 775-782.
81. McNair P, Madsbad S, Christensen MS, Faber OK, Transbol I, Binder C. Osteopenia an insulin treated diabetes mellitus. Diabetologia 1978; 15: 87-90.
82. McNair P, Christiansen C, Christensen MS, Madsbad S, Faber OK, Binder C, Tranabol I. Development of bone mineral loss in insulin-treated diabetes: a 1| years followup study in sixty patients. Eur. J. Clin Invest. 1981; 11: 55-59.
83. Pedrazzoni M, Ciotti G, Pioli G, Girasole G, Davoli L, Palummeri E, Passer! M. Osteocalcin levels in diabetic subjects. Calcif. Tissue Int. 1989; 45: 331-336.
84. Rico H, Hernandez ER, Cabranes JA, Gomez-Castresana F. Suggestion of a deficient osteoblast function in diabetes mellitus: the possible source of osteopenia in diabetics. Calcif. Tissue Int. 1989; 45: 71-73.
85. Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E. Influence of age, sex and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J. Clin. Endocrinol. Metab. 1985; 80: 1194-1202.
86. Stepan J, Havranek T, Formankova J, Skrha J, Skrha F, Pacovsky V. Bone isoenzyme of serum alkaline phosphatase in diabetes mellitus. Clin. Chim. Acta 1980; 105: 75-81.
87. Tibi L, Collier A, Patrick AW, Clarke BF, Smith AF. Plasma alkaline phosphatase isoenzymes in diabetes mellitus. Clin. Chim. Acta 1988; 177: 147-155.
88. Lian JB, Coutts M, Canalis E. Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvariae. J. Biol. Chem. 1985; 260: 8706-8710.
89. Mazess RB. Diabetes mellitus and risk of fracture. New Engl. J. Med. 1981; 304: 115.
90. Heath H, Melton LJ, Chu CP. Diabetes mellitus and risk of skeletal fracture. New Engl. J. Med. 1980; 303: 567-570.
91. De Leeuw I, Abs R. Bone mass and bone density in maturity-type diabetics measured by the 1251 photonabsorption technique. Diabetes 1977; 26: 1130-1135.
92. Meema HE, Meema S. The relationship of diabetes mellitus and body weight to osteoporosis in elderly females. Can. Med. Assoc. J. 1967; 96: 132-139.
93. Barrett-Connor E, Holbrook TL Sex differences in osteoporosis in older adults with non-insulin dependent diabetes mellitus. JAMA 1992; 268: 3333-3337.
94. van Daele PLA, Stolk RP, Burger H, Algra D, Grobee DE, Hofman A, Birkenhager JC, Pols HAP. Bone density in non-insulin dependent diabetes mellitus. Ann. Intern. Med. 1995; 112: 409-414.
95. Weinstock RS, Goland RS, Shane E, Clemens TL, Lindsay R, Bilezikian JP. Bone mineral density in women with type II diabetes mellitus. J. Bone Min. Res. 1989; 4:97-101.
96. Okuno Y, Nishizawa Y, Sekiya K, Hagiwara S, Miki T, Morii H. Total and regional bone mineral content in patients with non-insulin dependent diabetes mellitus. J. Nutr. Sci. Vitaminol. 1991; 37: S43-S49.
97. Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density measured by dual X-ray absorptiometry in patients with non-insulin dependent diabetes mellitus. Bone 1993; 14: 29-33.
98. Accili D. Molecular defects of the insulin receptor gene. Diabetes/Metabolism Reviews 1995; 11: 47-62.
99. Moller DE, Flier JS. Insulin resistance-mechanisms, syndromes, and implications. New Engl. J. Med. 1991; 325: 938-948.
100. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
101. Utsinger PD. Diffuse idiopathic skeletal hyperostosis. Clin. Rheum. Dis. 1985; 11: 323-351.
102. Littlejohn GO. Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis. Clin. Rheumatol. 1985; 4: 294-300.
103. Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis- insulin, insulin-like growth factor-l, growth hormone. J. Rheumatol. 1994; 21: 1725-1730.
104. Bauer DC, Browner WS, Caley JA, Orwoll ES, Scott JC, Black DM, Tao JL, Cummings SR. Factors associated with appendicular bone mass in older women. Ann. Intern. Med. 1993; 118:657-665.
105. Reid IR, Evans MC, Cooper GJS, Ames RW, Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am. J. Physiol. 1993; 65: E655-D659.
106. Smythe HA. Osteoarthritis, insulin and bone density. J. Rheumatol. 1987; 14 (Spec No): 91-93.
107. Sambrook PN, Eisman JA, Pocock NA, Jenkins AB. Serum insulin and bone density in normal subjects. J. Rheumatol. 1988; 15: 1415-1417.
108. Haffner SM, Bauer RL. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism 1993; 42: 735-738.
109. Plymate SR, Jones RE, Matej LA, Friedl KE. Regulation of sex hormone binding globulin production in Hep G2 cells by insulin. Steroids 1988; 52: 339-340.
110. Forestier J, Lagier R. Ankylosing hyperostosis of the spine. Clin. Orthopaed. 1971; 74: 65-83.
111. Julkunen H, Karava R, Viljanen V. Hyperostosis of the spine in diabetes mellitus and acromegaly. Diabetologia 1966; 2: 123-126.
112. Cassim B, Mody GM, Rubin DL. The prevalence of diffuse idiopathic skeletal hyperostosis in African blacks. Br. J. Rheumatol. 1990; 29: 131-132.
113. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet 1971; 2: 125-128.
114. Spagnola AM, Bennett PM, Terasaki PI. Vertebral ankylosing hyperostosis (Forestier's disease) and HLA antigens in Pima Indians. Arthritis Rheum. 1978; 4: 89-93.
115. Littlejohn GO, Smyth HA. Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J. Rheumatol. 1981; 8: 965-968.
116. Forgacs S, Halmos T, Salamon F. Bone changes in diabetes mellitus. Isr. J. Med. Sci. 1972; 8: 782-783.
117. Wolodzko L. Insulin secretion in women with hyperostosis frontalis externa. Endokrynol. Pol. 1980; 31: 43-50.
118. Burkhardt R, Moser W, Bartl R, Mahl G. Is diabetic osteoporosis due to microangiopathy? Lancet 1981; 1: 844.
119. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I. Is diabetic osteoporosis due to microangiopathy? Lancet 1981; 1: 1271.
120. Weintroub S, Eisenberg D, Tardiman R, Weissman SL, Salama R. Is diabetic osteoporosis due to microangiopathy? Lancet 1980; 2: 983.
121. Schneider LE, Nowosielski LM, Schedl HP. Insulin treatment of diabetic rats: effects on duodenal calcium absorption. Endocrinology 1977; 100: 67-73.
122. Frazer TE, White NH, Hough S, Santiago JV, McGee BR, Bryce G, Mallon J, Avioli LV. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J. Clin. Endocrinol. Metab. 1981; 53: 1154-1159.
123. Nyomba BL, Verhaeghe J,Thomasset M,LissensW, Bouillon R. Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 1989; 124: 565-572.
124. Verhaeghe J, Suiker AM, Van Bree R, Van Herck E, Jans I, Visser WJ, Allewaert K, Bouillon R. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats. Am. J. Physiol. 1993; 265: E215-E223.
125. Schedl HP, Heath H, Wenger J. Serum calcitonin and parathyroid hormone in experimental diabetes: effects of insulin treatment. Endocrinology 1977; 103: 1368-1373.
126. Locatto ME, Fernandez MC, Abranzon H, Caferra D, Puche RC. Calcium metabolism of rats with varying degrees of insulinopenia. Bone and Mineral 1990; 8: 119-130.
127. Verhaeghe J, Bouillon R, LissensW, VisserWJ, Van Assche FA. Diabetes and low Ca-P diet have opposite effects on adult and fetal bone mineral metabolism. Am. J. Physiol. 1988; 254: E496-E504.
128. Koopmans SJ, Radder JK, Krans HM, Berge RM. Biological actions of pancreatic amylin: reaction to glucose metabolism, diabetes, obesity and calcium metabolism. Neth. J. Med. 1992; 41:82-90.
129. TamuraT, Miyara C, Owan I.SudaT. Mechanism of amylin action in bone. J. Cell. Physiol. 1992; 153: 6-14.
130. Prager D, Melmed S. Editorial: Insulin and insulin-like growth factor receptors: are there functional distinctions? Endocrinology 1993; 132: 1419-1420.
131. Van Obberghen E. Signalling through the insulin receptor and the insulin-like growth factor-l receptor. Diabetologia 1994; 37: S125-S134.
132. Myers MG, Sun XJ, Cheatham B, Jachna BR. Glasheen EM, Backer JM, White MF. IRS-1 is a common element in insulin and insulin-like growth factor-l signaling to the phosphatidylinositol 3'-kinase. Endocrinology 1993; 132: 1421-1430.
133. Lammers R, Gray A, Schlessinger J, Ullrich A. Differential signalling potential of insulin- and IGF-l-receptor cytoplasmic domains. EMBO J. 1989; 8: 1369-1375.
134. De Meyts P. The structural basis of insulin and insulinlike growth factor-l receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 1994; 37: S135-S148.
135. Schmid C. IGFs: function and clinical importance 2 The regulation of osteoblast function y hormones and cytokines with special reference to insulin-like growth factors and their binding proteins. J. Intern. Med. 1993; 234: 535-542.
136. Bennett A, Chen T, Feldman D, Hintz RL, Rosenfeld RG. Characterization of insulin-like growth factor I receptors on cultured rat bone cells: regulation of receptor concentration by glucocorticoids. Endocrinology 1994; 115: 1577-1583.
137. Phillips LS, Young HS. Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats. Diabetes 1976; 25: 516527.
138. Michizuki H, Hakeda Y, Wakatsugi N, Usui N, Akashi S, SatoT, Tanaka K, Kumegawa M. Insulin-like growth factorI supports formation and activation of osteoclasts. Endocrinology 1992; 131: 1075-1080.
139. Hill PA, Reynolds JJ, Meikle MC. Osteoblasts mediate insulin-like growth factor-l and -II stimulation of osteoclast formation and function. Endocrinology 1995; 136: 124131.
140. Johansson AG, Lindh E, Ljunghall S. IGFs: function and clinical importance. 4. Growth hormone, insulin-like growth factor I, and bone: a clinical review. J. Intern. Med. 1993; 234: 553-560.
141. Raisz LG. Studies on bone formation and résorption in vitro. Horm. Res. 1984; 20: 22-27.